Other: MSCs ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
13. 多発性硬化症／視神経脊髄炎
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04749667 (ClinicalTrials.gov) | August 9, 2021 | 20/1/2021 | Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis | Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis | Multiple Sclerosis;Progressive Multiple Sclerosis | Other: MSCs;Drug: Saline | Haukeland University Hospital | University of Bergen;University Hospital Ulm;University Hospital, Akershus;St. Olavs Hospital;University Hospital of North Norway | Recruiting | 18 Years | 55 Years | All | 18 | Phase 1/Phase 2 | Norway |